export const sarcomaDataEn = {
  title: "Sarcoma",
  description: "This is a new additional research area for the project starting in December 2020. Large-scale computation and initial data analysis are underway to discover sarcoma biomarkers in muscle and bone tissues.",
  genes: [
    {
      name: "Sarcoma Genomics",
      full_name: "Molecular Classification of Sarcoma",
      role: "Rare Cancer Molecular Classification and Genomic Analysis",
      insight: "Sarcoma is a rare cancer with very diverse sites of origin and histological characteristics. The MCM project goes beyond simple classification by site, establishing a 'molecular classification system' based on genetic mutations to lay the foundation for personalized treatment.",
      article_id: 39,
      uniprot_id: "",
      deepDive: {
        story: {
          title: "Sarcoma: Drawing the Genomic Map of a Cancer with 70 Faces",
          analogy: "Sarcoma research is like solving a puzzle scattered into tens of thousands of pieces. The MCM research team is genetically classifying over 70 subtypes to find the optimal answer sheet for each patient.",
        },
        sections: [
          {
            id: "sarcoma-heterogeneity",
            title: "01. Existing Knowledge: Complexity of Rare Cancers in Connective Tissue",
            content: "Sarcoma is a group of 'rare cancers' that arise in the body's connective tissues such as fat, muscle, blood vessels, and bone. Although it accounts for less than 10% of all malignant tumors, it shows extreme diversity, occurring anywhere in the body and appearing in all age groups from infants to the elderly.",
            figureCaption: "Background Research: Analysis of underlying characteristics of sarcoma appearing across connective tissues"
          },
          {
            id: "diagnostic-dilemma",
            title: "02. Sarcoma Research Details: 'Molecular Classification' of 70 Subtypes",
            content: "There are 'over 70' known histological subtypes of sarcoma. To solve the 'diagnostic dilemma' where it is difficult to select the optimal treatment method based solely on the site of cancer occurrence, the MCM team is researching a new 'molecular classification' system based on gene fusions or mutations.",
            figureCaption: "Data Mining: Genomic data analysis strategy to classify over 70 subtypes"
          },
          {
            id: "sts-risk-reduction",
            title: "03. Environmental & Clinical Analysis: Improving Survival in High-Risk Soft Tissue Sarcoma",
            content: "The core goal of the research is to increase the survival rate of patients with 'Soft Tissue Sarcoma (STS)', which is difficult to treat, especially stage III patients with high metastasis risk. By identifying the genetic background of each subtype through large-scale genomic data mining, precise prognosis prediction and personalized anticancer strategy establishment, which were impossible in the past, are expected to become possible.",
            figureCaption: "Clinical Research Guide: Discovery of molecular targets for improving survival rates in high-risk patient groups"
          }
        ],
        conclusion: "Sarcoma research integrates vast genetic diversity at the molecular level, presenting new treatment possibilities for rare cancer patients."
      }
    }
  ]
};
